These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12739548)

  • 1. Ethical, social and public awareness issues in gene therapy EuropaBio.
    EuropaBio. Working Group on Gene Therapy
    J Biolaw Bus; 2002; 5(2):59-62. PubMed ID: 12739548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core ethical values: EuropaBio.
    EuropaBio
    J Biolaw Bus; 2002; 5(2):63. PubMed ID: 12825540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Displaced agendas: current regulatory strategies for germline gene therapy.
    Marden E; Nelkin D
    McGill Law J; 2000 May; 45(2):461-81. PubMed ID: 12688283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public information and the ethical responsibility of the industry.
    Bieri F
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):491-6. PubMed ID: 7885074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy. An ethical profile of a new medical territory.
    Fuchs M
    J Gene Med; 2006 Nov; 8(11):1358-62. PubMed ID: 17068829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ethics of human gene therapy.
    Walters L
    Brethr Life Thought; 1986; 31(4):215-22. PubMed ID: 16715558
    [No Abstract]   [Full Text] [Related]  

  • 7. The social, moral, ethical, legal and political implications of today's biological technologies: an Indian point of view.
    Bhargava PM
    Biotechnol J; 2006 Jan; 1(1):34-46. PubMed ID: 16892223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy bio-safety: scientific and regulatory issues.
    Gonin P; Buchholz CJ; Pallardy M; Mezzina M
    Gene Ther; 2005 Oct; 12 Suppl 1():S146-52. PubMed ID: 16231047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health issues related with the consumption of food obtained from genetically modified organisms.
    Paparini A; Romano-Spica V
    Biotechnol Annu Rev; 2004; 10():85-122. PubMed ID: 15504704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives.
    Altavilla A; Giaquinto C; Ceci A
    J Int Bioethique; 2008 Sep; 19(3):17-48, 121-2. PubMed ID: 19244940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference: a critical analysis of the regulatory and ethical issues encountered in the development of a novel therapy.
    McKnight R
    Albany Law J Sci Technol; 2004; 15(1):73-108. PubMed ID: 17340758
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical review of health-related biotechnology research in Africa: a role for the Pan African Bioethics Initiative (PABIN).
    Petros B
    Afr J Med Med Sci; 2007; 36 Suppl():43-7. PubMed ID: 17703564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future societal issues in industrial biotechnology.
    Schuurbiers D; Osseweijer P; Kinderlerer J
    Biotechnol J; 2007 Sep; 2(9):1112-20. PubMed ID: 17639531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tiered system for assessing the risk of genetically modified plants to non-target organisms.
    Garcia-Alonso M; Jacobs E; Raybould A; Nickson TE; Sowig P; Willekens H; Van der Kouwe P; Layton R; Amijee F; Fuentes AM; Tencalla F
    Environ Biosafety Res; 2006; 5(2):57-65. PubMed ID: 17328852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Industry involvement in Australian agrobiotechnology: the views of scientists.
    Lawrence G; Norton J
    Australas Biotechnol; 1994; 4(6):362-8. PubMed ID: 7765829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.
    Babor TF
    Addiction; 2009 Feb; 104 Suppl 1():34-47. PubMed ID: 19133913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring opportunities for collaboration between the corporate sector and the dental education community.
    Alexander D; Clarkson J; Buchanan R; Chadwick G; Chesters R; Drisko CL; Douglass CW; Farrell L; Fletcher K; Makoni F; Monaco M; Nordquist B; Park NI; Riggs S; Schou L; Smales FC; Stamm JW; Toh CG; Volpe T; Ward P; Warren P
    Eur J Dent Educ; 2008 Feb; 12 Suppl 1():64-73. PubMed ID: 18289269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the WTO/TBT enquiry point to monitor tendencies in the regulation of environment, health, and safety issues affecting the chemical industry.
    Pio Borges Menezes R; Maria de Souza Antunes A
    Environ Int; 2005 Apr; 31(3):407-16. PubMed ID: 15734193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.